Pisces: A multi-modal data augmentation approach for drug combination synergy prediction.

Journal: Cell genomics
Published Date:

Abstract

Drug combination therapy is promising for cancer treatment by reducing resistance and improving efficacy. Machine learning approaches to predicting drug combinations require massive training data. Here, we propose Pisces, a novel machine learning approach for drug combination synergy prediction. The key idea is to augment the sparse dataset by creating multiple views for each drug combination based on different modalities. We combined eight modalities of a drug to create 64 augmented views. By treating each augmented view as a separate instance, Pisces can process any number of drug modalities, circumventing the issue of missing modality. Pisces obtained state-of-the-art results on cell-line-based and xenograft-based drug synergy predictions and drug-drug interaction prediction. By interpreting Pisces's predictions using a genetic interaction network, we identified a breast cancer drug-sensitive pathway from BRCA cell lines. Collectively, the results show that Pisces effectively predicts drug synergy and drug-drug interactions through data augmentation and can be applied to various biological applications.

Authors

  • Hanwen Xu
    University of Washington, Seattle, WA, USA.
  • Jiacheng Lin
    Key Lab. of Advanced Manufacturing Technology of Ministry of Education, Guizhou University, Guiyang, China.
  • Addie Woicik
    Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA 98195, United States.
  • Zixuan Liu
    Department of Electrical Engineering, Stanford University, Stanford, CA 94305, USA.
  • Jianzhu Ma
    Toyota Technological Institute at Chicago, 6045 S. Kenwood Ave. Chicago, Illinois 60637 USA.
  • Sheng Zhang
    Department of Critical Care Medicine, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China.
  • Hoifung Poon
    Microsoft Research, Redmond, WA, USA. hoifung@microsoft.com.
  • Liewei Wang
    All authors: Mayo Clinic, Rochester, MN.
  • Sheng Wang
    Intensive Care Medical Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China.

Keywords

No keywords available for this article.